NETTERVILLE JAKE L

Average Profitability
15.82%
Insider Buys Quantity
4
Insider Buys Sum
$292,867.93
Insider Sells Quantity
14
Insider Sells Sum
$7.18M

Insider Activity of NETTERVILLE JAKE L

The largest purchase of all time was on 2010-08-18 and amounted to 6000 shares of Amedisys, Inc. for $142,824.

The largest sale of all time was on 2010-01-20 and amounted to 20000 shares of Amedisys, Inc. for $1.21M.

Biography of NETTERVILLE JAKE L

No biography is available at this moment.

2019-12-10SaleAmedisys, Inc.
AMED
director
1,000
0.0031%
$167.56$167,560+18.46%
2019-09-06SaleAmedisys, Inc.
AMED
director
1,000
0.0031%
$135.64$135,642+31.79%
2019-06-13SaleAmedisys, Inc.
AMED
director
1,863
0.0058%
$118.17$220,151+36.91%
2018-11-16SaleAmedisys, Inc.
AMED
director
2,000
0.0061%
$126.64$253,280+0.44%
2018-11-15SaleAmedisys, Inc.
AMED
director
4,788
0.0145%
$121.28$580,689+3.65%
2018-06-12SaleAmedisys, Inc.
AMED
director
8,192
0.0245%
$80.44$658,934+47.7%
2017-05-12SaleAmedisys, Inc.
AMED
director
20,000
0.0598%
$60.00$1.2M-6.39%
2015-03-13SaleAmedisys, Inc.
AMED
director
20,000
0.0612%
$27.20$544,028+42.71%
2012-05-23PurchaseAmedisys, Inc.
AMED
director
4,000
0.0132%
$9.74$38,948+16.8%
2011-11-14PurchaseAmedisys, Inc.
AMED
director
4,000
0.0138%
$11.75$47,000+5.36%
2010-08-18PurchaseAmedisys, Inc.
AMED
director
6,000
0.0214%
$23.80$142,824+19.92%
2010-01-20SaleAmedisys, Inc.
AMED
director
20,000
0.0726%
$60.50$1.21M-42.96%
2009-08-13SaleAmedisys, Inc.
AMED
director
20,000
0.0731%
$43.96$879,298+3.73%
2009-08-12SaleAmedisys, Inc.
AMED
director
10,000
0.0368%
$44.57$445,668+2.91%
2009-08-11SaleAmedisys, Inc.
AMED
director
10,000
0.0365%
$44.58$445,820+1.97%
2008-11-20SaleAmedisys, Inc.
AMED
director
4,000
0.0136%
$33.64$134,560+5.41%
2008-04-30SaleAmedisys, Inc.
AMED
director
6,000
0.022%
$50.00$300,000-6.21%
2006-02-28PurchaseAmedisys, Inc.
AMED
director
2,000
0.0125%
$32.05$64,096+21.19%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.